Skip to content
NAD+ Picks
Head to head

The Edit vs Taurus Meds

The clearest writing about compounded medication in the category, at $249, against the loudest claims in it, at $129.

By Laura BennettEvidence & trials

Updated

The Edit

Editorial

$249/mo

One of the few sellers that calls its product a compounded injectable in the product description itself, and says a prescription is required.

Pick it for: Anyone who weights honesty about regulatory status heavily

Taurus Meds

Editorial

$129/mo

Lists NAD⁺ at $129 against a struck-through $299, on a page whose product copy claims the shot gives near-immortality.

Pick it for: A price-driven buyer who reads past the copy

Our verdict

The Edit clearly states — that compounded medications are not FDA-approved and the FDA does not verify their safety, effectiveness or quality — and charges $249. Taurus Meds charges $129, says the injection gives near-immortality, and displays an FDA-approved badge beside compounded peptides. Neither product has outcome trials behind it, so you are choosing between paying a premium for candor and paying less to be marketed at.

What actually separates them

The Edit and Taurus Meds state different things about published price. Everything else they publish, they publish the same way.

The Edit costs $120 more than Taurus Meds — 93% more for the same molecule. Whether that buys anything is what the rest of this page is for.

Over twelve months that is about $1,548 at Taurus Meds against $2,988 at The Edit — a difference of $1,440.

 The EditTaurus Meds
Published price$249/mo$129/mo

Where they differ on what they tell you

Price is the easy comparison and often the least useful one. These are the places where one of these two answers a question the other leaves open.

The advertised price
The Edit advertises the rate it goes on charging, while taurus Meds leads with a price never charged.
The gap, over a year
On the injection both sell, Taurus Meds at $129 against The Edit at $249 is 93% — about $1440 a year, if you stay on either for twelve months and neither price moves.

What neither of them tells you

A comparison that only reports differences implies everything else is settled. Here it is not.

  • Neither publishes a milligram dose, so neither price can be compared with the other — or with anything else.
  • Both sell a compounded drug and neither names the pharmacy that compounds it.
  • Neither states whether any bloodwork is included, or what it would cost.
  • Neither publishes which states it can ship to.
  • Neither displays a LegitScript certification.

Before you choose either

Neither of these sellers publishes a milligram dose, so neither price can be compared with the other or with anything else — which is normal in this category and is exactly the problem. Ask both what dose the monthly price buys, and see the sellers that do publish one before you assume the cheaper sticker is the cheaper product.

Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.

All head-to-head comparisons · The full injections ranking